Immix Biopharma, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 1,108.41%13,554.33%1,653,811.87%
EBIT Margin 445.06%2,846.41%1,653,711.87%
EBITDA Margin 1,063.22%13,561.26%1,663,601.61%
Operating Margin 445.06%2,846.41%1,653,711.87%
Net Margin 1,125.62%13,557.67%1,655,877.87%
FCF Margin 396.85%884.12%1,490,604.23%
Leverage & Solvency
Interest Coverage Ratio -4.45-28.46-0.02M
Times Interest Earned -4.45-28.46-0.02M
Valuation
Enterprise Value 25.63M31.89M137.48M60.52M
Market Capitalization 25.63M31.89M137.48M60.52M
Return Ratios
Return on Sales 11.26%135.58%